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Rapid detection of cocaine, benzoylecgonine and
methylecgonine in ﬁngerprints using surface mass
spectrometry
Melanie J. Bailey,*†a Robert Bradshaw,†b Simona Francese,*b Tara L. Salter,c
Catia Costa,a Mahado Ismail,a,e Roger P. Webb,d Ingrid Bosman,e Kim Wolﬀf and
Marcel de Puite
Latent ﬁngerprints provide a potential route to the secure, high throughput and non-invasive detection of
drugs of abuse. In this study we show for the ﬁrst time that the excreted metabolites of drugs of abuse
can be detected in ﬁngerprints using ambient mass spectrometry. Fingerprints and oral ﬂuid were taken
from patients attending a drug and alcohol treatment service. Gas chromatography mass spectrometry
(GC-MS) was used to test the oral ﬂuid of patients for the presence of cocaine and benzoylecgonine. The
corresponding ﬁngerprints were analysed using Desorption Electrospray Ionization (DESI) which operates
under ambient conditions and Ion Mobility Tandem Mass Spectrometry Matrix Assisted Laser Desorption
Ionization (MALDI-IMS-MS/MS) and Secondary Ion Mass Spectrometry (SIMS). The detection of cocaine,
benzoylecgonine (BZE) and methylecgonine (EME) in latent ﬁngerprints using both DESI and MALDI
showed good correlation with oral ﬂuid testing. The sensitivity of SIMS was found to be insuﬃcient for
this application. These results provide exciting opportunities for the use of ﬁngerprints as a new sampling
medium for secure, non-invasive drug detection. The mass spectrometry techniques used here oﬀer a
high level of selectivity and consume only a small area of a single ﬁngerprint, allowing repeat and high
throughput analyses of a single sample.
Introduction
The drug testing industry is worth several billion dollars world-
wide, and is routinely used by probation services, prisons,
courts and other law enforcement agencies. Recently there has
been a push towards workplace drug testing as well as new
initiatives to test motorists for drug driving.1 Drug testing is
usually carried out by taking a sample of blood or urine from a
suspect and using either an antibody assay or chromatographic
analysis to detect the relevant drug and its metabolites.
However, these methods of sampling have limitations – blood
testing can require trained staﬀ, urine testing has associated
privacy concerns and in both cases the samples must be
treated as a biological hazard, which increases the complexity
of sample handling in terms of storage and disposal. Oral
fluid and sweat have been proposed as alternative non-invasive
collection matrices. These matrices, as well as oral fluid and
sweat, frequently require extraction steps from the collection
devices or precipitation from the biological fluids prior to ana-
lysis and this contributes to the cost of analysis.2
In contrast, a latent fingerprint can be deposited quickly
and transported easily. The identity of the donor is encapsu-
lated within the fingerprint ridge detail, making the test
impossible to falsify. It has recently been shown that drugs
and their metabolites can be detected in latent fingerprints
using antibody reagents.3 Whilst antibody reagents provide a
rapid screening test, non-specific binding can lead to false
positive results. Mass spectrometry techniques provide a
higher level of specificity, providing confirmation of the iden-
tity of the substance detected.
Recent work by Goucher et al.4 has shown that liquid
chromatography mass spectrometry (LC-MS) can be used to
detect lorazepam, methadone and their metabolites in latent
fingerprints. However, a positive detection was only achieved
when ten fingerprints were used (and consumed) in combi-
nation, making it impractical for use in the field as this†Equally contributing first authors.
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precludes repeat analysis. In contrast, recent developments in
surface mass spectrometry allow in situ analyses of a small
area (less than 100 × 100 µm) of a sample under atmospheric
pressure conditions. This provides the potential for rapid
sample throughput (often a few seconds per sample, compared
with several hours for LC-MS when sample preparation is
taken into account), a demonstration that the substance of
abuse resides in the fingerprint and not the substrate and the
opportunity to take repeat tests. These techniques have been
applied previously to fingerprints that have been deliberately
contaminated by drugs via contact5–7 but (to our knowledge)
not to unambiguously confirm the presence of drug meta-
bolites in the fingerprints of drug users. In order to confirm
ingestion of a drug (as opposed to contact), detection of drug
metabolites is essential. Rowell et al.8 used surface assisted
laser desorption ionization (SALDI) under vacuum conditions
to detect the major metabolite of methadone in natural finger-
prints, and was unable to confirm its presence using tandem
mass spectrometry.
Of the many surface mass spectrometry techniques avail-
able, matrix assisted laser desorption ionization (MALDI),9–11
desorption electrospray ionization (DESI)5 and secondary ion
mass spectrometry (SIMS)12–14 have been previously shown to
provide chemical images of endogenous and exogenous com-
pounds in a latent fingerprint. In this context, the techniques
oﬀer complementary features, these being high sensitivity
(MALDI), quantitative precision (SIMS) and high throughput
(DESI). All three of the techniques can operate under atmos-
pheric pressure conditions, allowing high throughput analysis.
In this paper, we will show for the first time that cocaine and
its metabolites benzoylecgonine (BZE) and methylecgonine
(EME) can be detected by these surface mass spectrometry
techniques in latent fingerprints, and in particular under
atmospheric pressure conditions, oﬀering an exciting new
opportunity for drug testing.
Materials and methods
Cocaine, EME, acetone and acetonitrile (ACN) were obtained
from Sigma Aldrich (St. Louis, USA). BZE was obtained either
from Sigma Aldrich (St. Louis, USA) or from Sigma Aldrich
(Poole, UK). Methanol was obtained either from Rathburn
(Walkerburn, UK) or from Sigma Aldrich (Poole, UK). Trifluoro-
acetic acid (TFA), and α-cyano-4-hydroxycinnamic acid
(α-CHCA) were purchased from Sigma Aldrich (Poole, UK).
Double-side conductive carbon tape was obtained from TAAB
(Aldermaston, UK).
Sample preparation
Latent fingerprints. Latent fingerprints were obtained from
five individuals who were attending a drug and alcohol treat-
ment service to receive treatment for drug dependence.
“Natural” fingerprints were deposited onto clean glass slides
at a pressure between 400–1000 g and barcoded, before being
shipped to the two analyzing laboratories. The fingerprints
were then stored in a freezer at each lab at −80 °C. A corres-
ponding oral fluid sample was collected from each patient
using a Quantisal™ collection kit, Alere Toxicology, UK. The
oral fluid samples were screened for cocaine and benzoyl-
ecgonine BZE using a standard drug screening procedure utilizing
GC-MS/MS at LGC Forensics, Teddington, Middlesex. A favour-
able ethical opinion for sample collection and analysis was
granted from the National Research Ethics Service. In line with
the ethics protocol, the patients were not asked whether they
had used drugs.
MALDI. For MALDI analyses, the fingerprints were taken
out of storage and a 0.5 µL BZE standard solution at a concen-
tration of 100 µg mL−1 in 1 : 9 methanol : water mixed 1 : 1
with a solution of 5 mg mL−1 α-CHCA in 70 : 30 ACN: 0.5%
TFA was then spotted onto an area of the glass slide away from
the mark. Both the fingerprint and the standard on the glass
slide were allowed to dry in a vacuum desiccator for
20 minutes prior to analysis. The entire fingermark was
spotted at random points with the MALDI matrix before spec-
tral acquisition. Fingerprints were analysed approximately
3 months after deposition.
DESI and SIMS. Gels containing standards of cocaine, BZE
and EME at concentrations of 5, 50, 500 and 5000 ng ml−1
were pipetted onto glass slides and smeared across the slides
to create a uniform layer. The gels, which were a few mm in
thickness, were made of synthetic gelatine (Sigma Aldrich, UK)
and analysed using DESI and SIMS. No sample preparation
was required for the fingerprint samples. Fingerprints were
analysed approximately 1 month after deposition.
Instrumentation
MALDI ion mobility tandem mass spectrometry
(MALDI-IMS-MS/MS) analysis was conducted using a Synapt™
G2 HDMS mass spectrometer (Waters Corporations, Manche-
ster, UK) incorporating a Nd:YAG laser operating at 1 kHz.
Spectra were acquired in positive and resolution (‘Res’) mode
in the mass range between m/z 100–1000 with a laser power of
200 (a.u.). Transfer fragmentation was used, allowing for ions
to be separated based on their mobility and then subjected to
collision induced dissociation in the Transfer T-Wave™. This
maintained that product ions retained the same ion drift time
as their corresponding precursor ion. Collision energy was
applied at 26 eV for the dissociation of BZE. Prior to analysis,
calibration was performed in the specified mass range using
Glu-1-fibrinopeptide. Data processing of all spectra was per-
formed using MassLynx 4.1 (Waters Corporation, Manchester,
UK).
DESI analyses were carried out at the National Physical Lab-
oratory, Teddington using a DESI 2D Omni Spray Ion Source
(Prosolia, Indianapolis, IN, USA) and an LTQ Orbitrap Velos
mass spectrometer (Thermo Scientific, Bremen, Germany),
optimised as outlined in ref. 15. Data were acquired using the
Orbitrap mass analyser with the highest resolution setting of
100 000 (at m/z 400), except where stated when the linear ion
trap analyser was used. The solvent composition was 90 : 10
MeOH : H2O supplied at a flow rate of 1.5 µL min
−1 using a
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5 kV bias. The spray was directed through a 50 micron capil-
lary, giving a spot of approximately 300 × 300 µm on the
sample.16 Approximately 1 mm2 of sample was consumed
during the analysis. Spectra were collected in positive ion
mode using both full scan mode and MS/MS mode.
SIMS analyses were carried out using an ION-TOF GmbH
(Münster, Germany) TOF SIMS 5 instrument at the University
of Surrey, UK. A 25 keV Bi3
+ primary ion beam delivering 0.18
pA of current was employed. Images were acquired at 128 ×
128 resolution in the MacroRaster mode of operation. Scans of
500 × 500 µm were acquired. Image data were acquired
using 512 cycles per pixel point with 1 scan per pixel. A
cycle time of 100 μs was employed. Mass calibration was per-
formed by assigning peaks with a known mass using IonSpec
software (version 4.1). Calibration was carried out using the
following ions: CH3, Na, C2H3, CHO, C2H5, C3H5, C2H3O,
C3H7, C2H5O, C4H5, C3H3O, C4H7, C3H5O, C4H9, C6H5, C7H7,
and Si2C5H15O.
Results
MALDI IMS-MS/MS
The ion mobility function can provide superior separation of
isobaric ions and sensitivity, as ions are separated, in addition
to their m/z, also on the basis of a specific ‘drift time’ (DT)
that is unique to that particular ion as it is linked to their
collisional cross section.17 This allows for the reliable detec-
tion of biologically relevant concentrations. In this instance,
MALDI-IMS-MS/MS has been employed to confirm the pres-
ence of BZE based on the matching of the product ions and
their DT’s in the fingerprint and in the BZE standard. MALDI
IMS-MS/MS analysis of both the standard and the mark
allowed for Drift Scope Plots (a graphical representation of the
ion mobility separation) to be generated and select DT regions
of interest containing both the parent and the corresponding
product ions (Fig. 1A). Spectra from these acquisitions were
interrogated for a product ion derived from the collision
induced dissociation of BZE which directly corresponded to
those observed in the standard (m/z 168.1033) (Fig. 1B). Drift
time chromatograms could then be produced based on the DT
of this product ion, showing that the BZE product ion in the
standard and the mark directly coincided (Fig. 1C). These data
prove, unequivocally, that it is possible to detect excreted BZE
contained within the fingerprint residue with corresponding
oral fluid above the 16 ng ml−1 cut-oﬀ determined by the
service provider’s GC-MS protocol18 (although it is unknown at
the present what is the lowest limit of detection and limit of
quantification for fingerprint residue) and highlight the
selectivity and sensitivity of modern analytical techniques
such as ion mobility mass spectrometry.
DESI
Analysis of the standards showed that detectable signals for
cocaine and BZE were present above 5 ng ml−1, and above
50 ng ml−1 for EME. In Fig. 2, spectra are presented which show
Fig. 1 Detection of BZE from a ﬁngerprint from a drug user in a rehabilitation centre by MALDI IMS-MS/MS. (Fig. 1A) Drift scope plots of BZE stan-
dard and BZE in the ﬁngerprint (generated through transfer fragmentation experiment). (Fig. 1B) MS/MS spectra of BZE standard and BZE in the
ﬁngerprint after the selection of the BZE parent ion and products ion within the same drift time plume in the ﬁngerprint and in the standard. Selec-
tion of the ion product at m/z 168.1033 in common to the BZE standard and BZE in ﬁngerprint showing superimposable drift time chromatograms.
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positive identification of cocaine, BZE and EME in a finger-
print sample. Fig. 2A shows the MS/MS spectrum from a fin-
gerprint for ions with m/z 304, with the (M + H)+ peak for
cocaine detected at a mass accuracy of 4.8 ppm (in full scan
mode this was improved to 0.807 ppm) and the detection of
the fragment ion at m/z 182. Similarly, Fig. 2B shows the MS/
MS spectrum from a fingerprint for ions with m/z 290, with the
(M + H)+ peak for BZE detected at a mass accuracy of 5.0 ppm
(0.016 ppm in full scan mode), and detection of the fragment
ion at m/z 168, confirming the presence of BZE in the finger-
print. No signal was detected when the spray was moved away
from the fingerprint. Finally, Fig. 2C shows the MS/MS spec-
trum, using the linear ion trap analyser, from a fingerprint for
ions with m/z 200, with the (M + H)+ peak for EME and detec-
tion of the fragment ion at m/z 182, confirming the presence
of EME in the fingerprint. Using the Orbitrap mass analyser in
full scan mode, EME was detected with a mass accuracy of
0.200 ppm. Table 1 compares the results of oral fluid testing
and fingerprint testing from DESI of four donors’ fingerprints.
Donors 1a and 1b represent diﬀerent fingerprints from the
same donor, and there is direct correspondence between the
oral fluid test and the two fingerprints analysed by DESI. A
similar result is seen for Donor 3. Donor 2’s oral fluid tested
negative, and the absence of a detectable signal in the DESI
spectra from Donor 2’s fingerprints are in direct agreement
with this. The oral fluid test for Donor 4 tested positive for
cocaine and this is also detected in Donor 4’s fingerprint.
However, EME and BZE were not detected in the fingerprints
from this donor.
Fig. 2 Detection of cocaine, BZE and EME in a ﬁngerprint from a drug
user attending a rehabilitation centre using DESI MS/MS. Spectra from a
ﬁngerprint with ions of m/z (Fig. 1A) 304 (cocaine) (Fig. 1B) 290 (BZE)
(Fig. 1C) 200 (EME).
Table 1 Oral ﬂuid test results and corresponding DESI and MALDI
signals in the ﬁngerprints of ﬁve donors
Donor
Oral fluid
screening result
DESI fingerprint analysis
Cocaine BZE EME
DESI
1a Positive y y y
1b Positive y y y
2 Negative n n n
3 Positive y y y
4 Positive y n n
MALDI
5 Positive y y N/A
Table 2 DESI signals for cocaine, BZE and EME across three positions
on three diﬀerent ﬁngerprints of two donors
Position Cocaine BZE EME
Donor 6
Lthumb 1 ✓ ✓ ✓
2 ✓ ✓ ✓
3 ✓ ⊠ ✓
Rindex 1 ✓ ✓ ✓
2 ✓ ✓ ✓
3 ✓ ✓ ✓
Rring 1 ✓ ✓ ✓
2 ✓ ✓ ✓
3 ✓ ✓ ✓
Donor 7
Rindex 1 ✓ ✓ ✓
2 ✓ ✓ ✓
3 ✓ ✓ ✓
Rmiddle 1 ✓ ✓ ✓
2 ✓ ✓ ✓
3 ✓ ✓ ✓
Rthumb 1 ✓ ✓ ✓
2 ✓ ✓ ✓
3 ✓ ✓ ✓
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Table 2 presents data relating to the qualitative repeatability
of the DESI method. Three fingerprints were taken from each
of a further two donors who tested positive for cocaine in their
oral fluid. Three separate points were analysed on each finger-
print. Table 2 shows that cocaine and EME were detected at
every point analysed. BZE was detected in 17 out of 18 of the
analysis points.
SIMS
SIMS analysis of the standards revealed peaks at m/z 168, 124,
105 and 82, representing fragments of cocaine, BZE and EME.
Molecular ion peaks could be seen only with the highest con-
centration of the analytes. In the latent fingerprint samples,
only the peak at m/z 82 was detected.
Discussion
MALDI IMS-MS/MS and DESI analysis of a “natural” latent fin-
gerprint allowed for the successful detection of the excreted
primary metabolite, BZE. DESI was also able to detect EME
and, at the time of the MALDI analysis, researchers were
specifically asked to look for BZE only, therefore no compara-
tive conclusions can be made on the feasibility of MALDI to
detect this secondary metabolite.
The ability to detect excreted substances in latent finger-
prints proves that surface mass spectrometry techniques could
provide the drug testing industry with an exciting new and
complementary tool, potentially allowing diﬀerentiation
between drug consumption and contact solely based on the
presence of metabolites in the residue. The significance of
detecting cocaine metabolites in a fingerprint is currently
unknown, because it is not known whether cocaine in finger-
print residue from contact could metabolise on the skin’s
surface. Furthermore, the possibility of absorption and metab-
olism of contact residues and the potential for secondary
transfer has never been investigated. Although an image of the
distribution of these excreted illicit substances in the finger-
print samples has not yet been attempted by either technique,
the use of these techniques in profiling mode enables a rapid
confirmatory screening for drugs of interest in less than
2 minutes.
The correspondence between the DESI and MALDI results
and the oral fluid measurements is promising, but also shows
the importance of developing a quantitative test with a cut-oﬀ
level. The DESI result for Donor 4 shows that whilst this
donor’s oral fluid was above the oral fluid screening test cut-
oﬀ level, only cocaine (and not BZE or EME) was detected in
the fingerprint. This could be due to a diﬀerence in the (cur-
rently unknown) detection window for these metabolites in
fingerprints compared with oral fluid or it may be a conse-
quence of insuﬃcient sensitivity of the DESI technique.
No quantification of the DESI data was attempted at this
stage since a matrix-matched standard does not exist.
Additionally, since the fingerprints are not spatially uniform,
an appropriate sampling regime should be developed. The
diﬃculty with quantification of a substance within fingerprint
residue is that there is currently no accepted method for deter-
mining how much material was deposited in the finger depo-
sition. In contrast, in blood, urine or oral fluid, the sample
volume is known. It has been shown previously using an
LC-MS method to detect caﬀeine in fingerprints that diﬀerent
fingers gave diﬀerent results, presumably due to diﬀerent
contact pressure and/or deposition area from diﬀerent
fingers.19 We are currently investigating the validity of using
diﬀerent endogenous compounds within a fingerprint for nor-
malisation purposes. Further studies are necessary in this area
to establish a quantitative procedure.
Whilst SIMS has been previously shown to be a useful tech-
nique for imaging endogenous compounds in latent finger-
prints,13,14 its suitability for the detection of drug metabolites
in fingerprints is questionable, under the analytical conditions
used here. The high level of fragmentation results in only the
detection of the fragment ion at m/z 82 in fingerprint samples
and standards of concentrations below 5000 ng ml−1. This
fragment is common to cocaine, BZE and EME as well as other
compounds, and therefore the selectivity is insuﬃcient for
toxicological application. It should be noted however, that Ar
cluster SIMS sources can provide significantly higher mole-
cular ion yields than Bi SIMS for organic compounds, and this
may yield the desired selectivity in fingerprint samples. If this
were the case, SIMS may provide superior opportunities for
quantification compared with DESI and MALDI.
Conclusion
We have demonstrated the use of established and emerging
analytical techniques for the analysis of cocaine and its
metabolites in natural fingerprints. DESI was carried out
under ambient conditions, and atmospheric pressure MALDI
systems are also available. This, combined with the ability to
analyse the sample in situ and with minimal sample prepa-
ration allows for very rapid sample throughput compared
with chromatographic methods. The high sensitivity of the
methods and selectivity to the analytes described has
enabled us to detect metabolites of cocaine drugs from those
who use illicit substances. Secondly, although the finger-
prints are not spatially uniform, we are optimistic that these
approaches can be developed for quantitative analysis of
fingerprint residues.
Abbreviations
GC-MS Gas chromatography mass spectrometry
BZE Benzoylecgonine
EME Methylecgonine
DESI Desorption electrospray ionisation mass
spectrometry
MALDI-IMS-MS/MS Matrix assisted laser desorption ion
mobility tandem mass spectrometry
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SIMS Secondary ion mass spectrometry
LC-MS Liquid chromatography mass spectrometry
SALDI Surface assisted laser desorption ionisation
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